Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke

July 8, 2025 updated by: Soo Yeon Sun, PT, PhD, Alvernia University

Investigating Effects of High-intensity Gait Training on Gait Function, Balance and Depression Following Stroke and the Impact of Social Determinants of Health and Depression on Patients' Adherence to Physical Therapy

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvements in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.

Study Overview

Status

Terminated

Conditions

Detailed Description

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvement in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.

The findings from this study will help the researchers and clinicians decide how to help people with stroke better. Further, the findings will determine how depressive symptoms, health literacy, and other factors such as language and education affect attendance to therapy.

About 24 subjects will take part in this research.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18104-2310
        • Lehigh Valley Health Network Outpatient Neurologic Rehab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years of age or older
  • English or Spanish speaking
  • A diagnosis of stroke (intracerebral hemorrhage or acute ischemic stroke)
  • Referred to LVHN Outpatient Neurologic Rehab (hereafter referred to as outpatient PT)

Exclusion Criteria:

  • Unable to follow 1-step commands
  • > 220 pounds (100 kg)
  • Height < 5'0" or > 6'4"
  • Unable to take a few steps with assistance
  • A score of ≥ 50/56 on Berg Balance Scale (BBS)
  • A score of ≥ 26/30 on Functional Gait Assessment (FGA)
  • Resting blood pressure >180/110 mmHg
  • Resting heart rate > 120 bpm
  • Severe cardiac disease (New York Heart Association Classification IV)
  • Severe spasticity (Modified Ashworth score > 3)
  • Unstable spine or unhealed pelvic/limb fractures
  • Active heterotrophic ossification impacting lower extremity range of motion
  • Significant lower or upper extremity contractures
  • Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion
  • Pregnancy
  • Colostomy
  • Poor skin integrity
  • Unresolved deep vein thrombosis
  • Lower limb prosthesis or amputation
  • Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs
  • ROM restrictions preventing normal, reciprocal gait
  • Inability to stand for > 3 minutes due to pain or orthostatic hypotension
  • Pusher syndrome
  • Cortical blindness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High intensity gait training
Participants will receive 20 sessions of vigorous walking practice. These sessions are 2-3 times a week.
Participants will practice walking that is vigorous enough to keep their heart rate over a certain level during their physical therapy sessions. During the sessions, participants will walk and step vigorously enough to keep the heart rate between 60-80% of their maximum heart rate. Maintaining this heart rate during exercise helps to improve heart health and walking, which can affect people after a stroke.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3-meter backwards walk test
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Measures backward gait velocity
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
6-minute walk test
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Measures aerobic capacity and endurance
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
10-meter walk test
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Measures forward gait velocity
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Surface electromyography (EMG)
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Electromyographical recording of 8 leg muscles () is done during forward and backward walking tests.The EMG will be recorded during 3-meter Backward Walk Test, 6-minute Walk Test, and 10-meter Walk Test in all participants
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Berg Balance Scale
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
a 14-item objective measure that assesses static balance and fall risk in adults. Berg balance scale scoring ranges from 0 to 56, with higher scores mean a better outcome.
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Functional Gait Assessment
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
This scale assess postural stability during walking and assesses an individual's ability to perform multiple motor tasks while walking. Scoring for each FGA item ranges from 0 for severe impairment to 3 for normal performance. The highest score possible is 30, with higher scores correlating better gait function.
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Borg Rating Scale of Perceived Exertion (RPE)
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
RPE is used to prescribe and monitor exercise intensity and correlates well with physiological measures of exercise intensity, including heart rate. The Borg Rating Scale of Perceived Exertion will be measured in all participants at the completion of 6 Minute Walk test. It ranges from 6 to 20, where 6 means "no exertion at all" and 20 means "maximal exertion." A lower score indicates a better exercise endurance.
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Patient Health Questionnaire (PHQ-9)
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Depressive symptom questionnaire. As a severity measure, the PHQ-9 score can range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). A lower score indicates less depressive symptoms.
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
Rate of patient attendance (Compliance) to physical therapy
Time Frame: Participant's attendance to physical therapy is tracked throughout the intervention sessions.
Greater than or equal to 80% attendance to physical therapy is considered compliance to physical therapy.
Participant's attendance to physical therapy is tracked throughout the intervention sessions.
Newest Vital Sign
Time Frame: Pre-intervention (baseline)
The NVS is a 6-question screening tool that identifies participants' risk of low or limited health literacy based on interpreting an ice cream nutrition label. It is available from Pfizer Pharmaceutical Company. The level of health literacy for each individual will be categorized based on the scores: a score of 0-1 suggests a high likelihood of limited literacy, a score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always indicates adequate literacy. This categorical variable will be used to determine the association with adherence to physical therapy.
Pre-intervention (baseline)
Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: Pre-intervention (baseline)
The MSPSS is a 12-item self-administered scale that measures social support. It contains 12-items, rated on a 7-point Likert-type scale, ranging from 1 "very strongly disagree" to 7 "very strongly agree." The scale was divided into 3 subscales: family, friends, and significant other, with each section consisting of 4 items. The response scale ranges from 12 to 84. Higher scores indicate a greater family social support.
Pre-intervention (baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Soo Yeon Sun, PhD, Alvernia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2024

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

May 30, 2025

Study Registration Dates

First Submitted

March 25, 2024

First Submitted That Met QC Criteria

April 15, 2024

First Posted (Actual)

April 18, 2024

Study Record Updates

Last Update Posted (Actual)

July 11, 2025

Last Update Submitted That Met QC Criteria

July 8, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on High intensity gait training

Subscribe